177 related articles for article (PubMed ID: 17714059)
1. Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation.
Ng FL; Holt DW; MacPhee IA
Expert Opin Pharmacother; 2007 Sep; 8(13):2045-58. PubMed ID: 17714059
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.
Ekbal NJ; Holt DW; Macphee IA
Pharmacogenomics; 2008 May; 9(5):585-96. PubMed ID: 18466104
[TBL] [Abstract][Full Text] [Related]
3. Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?
MacPhee IA; Fredericks S; Holt DW
Expert Opin Pharmacother; 2005 Dec; 6(15):2593-605. PubMed ID: 16316299
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.
Cattaneo D; Baldelli S; Perico N
Am J Transplant; 2008 Jul; 8(7):1374-83. PubMed ID: 18510642
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.
Kurzawski M; Droździk M
Pharmacogenomics; 2013 Jul; 14(9):1099-118. PubMed ID: 23837483
[TBL] [Abstract][Full Text] [Related]
6. Practicability of pharmacogenetics in transplantation medicine.
van Gelder T; van Schaik RH; Hesselink DA
Clin Pharmacol Ther; 2014 Mar; 95(3):262-4. PubMed ID: 23995265
[TBL] [Abstract][Full Text] [Related]
7. The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administration.
Fredericks S; Holt DW; MacPhee IA
Am J Pharmacogenomics; 2003; 3(5):291-301. PubMed ID: 14575518
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms influencing therapy and susceptibility to rejection in organ allograft recipients.
Poli F; Piccolo G; Scalamogna M
BioDrugs; 2002; 16(1):11-7. PubMed ID: 11908998
[TBL] [Abstract][Full Text] [Related]
9. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs.
Picard N; Bergan S; Marquet P; van Gelder T; Wallemacq P; Hesselink DA; Haufroid V
Ther Drug Monit; 2016 Apr; 38 Suppl 1():S57-69. PubMed ID: 26469711
[TBL] [Abstract][Full Text] [Related]
11. Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation.
Ware N; MacPhee IA
Curr Opin Mol Ther; 2010 Jun; 12(3):270-83. PubMed ID: 20521216
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives.
Anglicheau D; Legendre C; Thervet E
Transplantation; 2004 Aug; 78(3):311-5. PubMed ID: 15316356
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
Oscarson M
Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of mycophenolate mofetil: a promising different approach to tailoring immunosuppression?
Betonico GN; Abudd-Filho M; Goloni-Bertollo EM; Pavarino-Bertelli E
J Nephrol; 2008; 21(4):503-9. PubMed ID: 18651539
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics in drug regulation: promise, potential and pitfalls.
Shah RR
Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1617-38. PubMed ID: 16096112
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 3A polymorphisms and immunosuppressive drugs.
Thervet E; Legendre C; Beaune P; Anglicheau D
Pharmacogenomics; 2005 Jan; 6(1):37-47. PubMed ID: 15723604
[TBL] [Abstract][Full Text] [Related]
17. Genes and beans: pharmacogenomics of renal transplant.
Murray B; Hawes E; Lee RA; Watson R; Roederer MW
Pharmacogenomics; 2013 May; 14(7):783-98. PubMed ID: 23651025
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of calcineurin inhibitors in renal transplantation.
Coto E; Tavira B
Transplantation; 2009 Aug; 88(3 Suppl):S62-7. PubMed ID: 19667964
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics?
Burckart GJ; Liu XI
Ther Drug Monit; 2006 Feb; 28(1):23-30. PubMed ID: 16418689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]